Katalog der Deutschen Nationalbibliothek

Go to:

Knowledge Web

Person
Person

Person

Inken Hilgendorf (1974-)

Ärztin

Name

Inken Hilgendorf

Time

1974- (Date of birth and death)

Place

Grevesmühlen (Geburtsort)
Deutschland

Gender

weiblich

Academic degree

Dr. med. habil.

Profession

Ärztin (characteristic profession)

Variant

I. Hilgendorf

Related

Universität Rostock
Universität Rostock. Medizinische Fakultät
Klinik für Innere Medizin II (Jena). Hämatologie und Internistische Onkologie
Universitätsklinikum Jena. Institut für Infektionsmedizin und Krankenhaushygiene
Friedrich-Schiller-Universität Jena. Institut für Mikrobiologie

Further information

Diss. Technisch-Naturwissenschaftliche Fakultät; Studium der Humanmedizin
2012 Habilitation an der Medizinischen Fakultät der Universität Rostock

Record type

Person

GND-Identifier

123769884

Record ID

123769884

Involved in

show all

Onkopedia: What’s New? Systemic Tumor Treatment in Pregnancy

COVID-19-Impfung nach allogener Blutstammzelltransplantation : eine Bestandsaufnahme

Changes in chronic graft-versus-host disease treatment over time: a 15-years survey within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland

Correction to: Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia

Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia

Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

Recht auf Vergessenwerden : keine Benachteiligung von jungen Erwachsenen mit Krebs mehr zulassen

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies

Allogene Stammzelltransplantation bei myeloproliferativen Neoplasien

Pomalidomide combinations are a safe and effective option after daratumumab failure

Isolation of Hafnia paralvei co-harbouring bla NDM-1 and bla VIM-1 in a woman who underwent allogeneic hematopoietic stem cell transplantation

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission : a study from the Acute Leukemia Working Party of the EBMT

Isolation of Hafnia paralvei co-harbouring bla NDM-1 and bla VIM-1 in a woman who underwent allogeneic hematopoietic stem cell transplantation

Pomalidomide combinations are a safe and effective option after daratumumab failure

Pomalidomide combinations are a safe and effective option after daratumumab failure

Prädiktoren für das Outcome von Patienten mit einer aktiven hämatologischen Erkrankung

Psychosocial distress in young adults surviving hematological malignancies : a pilot study

Psychosocial distress in young adults surviving hematological malignancies: a pilot study

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma

Langzeitüberleben bei Krebs: Definitionen, Konzepte und Gestaltungsprinzipien von Survivorship-Programmen

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

Comparison of cytomegalovirus-specific immune cell response to proteins versus peptides using an IFN-γ ELISpot assay after hematopoietic stem cell transplantation

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party

End of life care nach allogener Stammzelltransplantation - Eine monozentrische retrospektive Untersuchung

High mortality of COVID-19 early after allogeneic stem cell transplantation: a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia

Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm

Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia

HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient

Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors

Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile

Melphalan 200 mg/m2 does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients

Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation

Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health

Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity

A 19-year-old patient with atypical chronic myeloid leukemia

Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors – presentation of the CARE for CAYA-Program study protocol and associated literature review

Stationäre Rehabilitation nach allogener Stammzelltransplantation – Rahmenempfehlungen zur Qualitätssicherung

Chemo-Immuntherapie in einem präklinischen MLH1-knockout Modell

Krebs bei Jugendlichen und jungen Erwachsenen : Status quo der interdisziplinären Versorgung in Deutschland

Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients

The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey

A Mosquito Bite with Devastating Complications in an Immunocompromised Patient

Der Einfluss von Exergaming und Physiotherapie auf die physische Leistungsfähigkeit vor und nach Blutstammzelltransplantation : eine prospektive, randomisierte Studie

A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation

Sport- und physiotherapeutische Maßnahmen zur Behandlung der chronischen Graft-versus-Host-Krankheit
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal